Evaluation of the Effectiveness of Pharmacists in Implementing the SCRIPT Protocol

Providence Medical Research Center

Status: Completed

Conditions: Pregnancy

Treatments: Behavioral: pharmacist nicotine cessation counseling using SCRIPT protocol

Study type: Interventional

Funder types: Other

Identifiers

NCT02433860

A20010724157261

Details and patient eligibility

About

There is a significant need for nicotine cessation programs for pregnant women in Spokane County. SCRIPT has been proven to be an effective method for smoking cessation in pregnant women. This study will evaluate the success of SCRIPT delivered by pharmacists. At the end of the study, the investigators hope to have three questions answered: 1) what is the quit rate of pregnant women in the Spokane area who receive the SCRIPT intervention delivered by pharmacists? 2) How does the quit rate compare to the quit rates of SCRIPT programs delivered by other health care providers as documented in the literature? And 3) Does the SCRIPT intervention have a significant effect on quit rates for pregnant women compared to current Spokane county quit rates? Urine cotinine tests will be used to document smoking status before delivery of the SCRIPT program, approximately one week after quit date and at >36 wks gestation or at delivery for study participants.

Full description

1. The goal of this project is to evaluate the success of pharmacists in delivering the SCRIPT smoking cessation program. The research questions that need to be addressed are: i. What is the quit rate of pregnant women in the Spokane area who receive the SCRIPT intervention delivered by a pharmacist? ii. How does this quit rate compare to the quit rates of other SCRIPT programs given by other health care providers (social workers, nurses, etc.)? iii. Does the SCRIPT intervention have a significant effect on quit rates for smoking pregnant women compared to current Spokane county quit rates?

Enrollment: 8 patients

Sex: Female

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Pregnant
• nicotine use
• English speaking
• 18 years of age or older

Exclusion criteria

• Males due to pregnancy status not applicable

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

8 participants in 1 patient group

pregnant nicotine users

Experimental group

Description:

watch video and tobacco cessation counselling using SCRIPT protocol

Treatment:

Behavioral: pharmacist nicotine cessation counseling using SCRIPT protocol